Human-associated fluoroquinolone-resistant Escherichia coli clonal lineages, including ST354, isolated from canine feces and extraintestinal infections in Australia

Microbes and Infection

Volumn 17, Issue 4, 2015, Pages 266-274

  Guo, SiYu ^a,b   Wakeham, David ^c   Brouwers, Huub J M ^b   Cobbold, Rowland N ^a   Abraham, Sam ^c   Mollinger, Joanne L ^a,d   Johnson, James R ^e   Chapman, Toni A ^b   Gordon, David M ^f   Barrs, Vanessa R ^g   Trott, Darren J ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NSW DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d DEPARTMENT OF AGRICULTURE AND FISHERIES   (Australia)

^e VA MEDICAL CENTER   (United States)

^f AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Extended spectrum cephalosporin resistant; Extraintestinal pathogenic Escherichia coli; Fluoroquinolone resistant; Phylogenetic group D

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; CEPHALOSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DOG; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O15:K53:H1; EXTRAINTESTINAL INFECTION; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; FECES ANALYSIS; GENE CLUSTER; GENETIC IDENTIFICATION; GENOTYPE; HUMAN; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; ANIMAL; DOG DISEASE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; GENETICS; IMMUNOLOGY; MICROBIOLOGY; VETERINARY; VIRULENCE;

CANIS FAMILIARIS; ESCHERICHIA COLI;

ANIMALS; AUSTRALIA; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FLUOROQUINOLONES; HUMANS; VIRULENCE;

EID: 84936952507     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.12.016     Document Type: Article

References (29)

1. Johnson J.R., Russo T.A. Extraintestinal pathogenic Escherichia coli: "the other bad E. coli". J Lab Clin Med 2002, 139:155-162.
2. Ewers C., Grobbel M., Stamm I., Kopp P.A., Diehl I., Semmler T., et al. Emergence of human pandemic O25: H4-ST131 CTX-M-15 extended-spectrum-β-lactamase-producing Escherichia coli among companion animals. J Antimicrob Chemother 2010, 65:651-660.
3. Guo S., Brouwers H.J., Cobbold R.N., Platell J.L., Chapman T.A., Barrs V.R., et al. Fluoroquinolone-resistant extraintestinal pathogenic Escherichia coli, including O25b-ST131, isolated from faeces of hospitalized dogs in an Australian veterinary referral centre. J Antimicrob Chemother 2013, 68:1025-1031.
4. Ochman H., Selander R.K. Standard reference strains of Escherichia coli from natural populations. J Bacteriol 1984, 157:690-693.
5. Johnson J.R., Murray A.C., Gajewski A., Sullivan M., Snippes P., Kuskowski M.A., et al. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother 2003, 47:2161-2168.
6. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
7. Gordon D.M., Clermont O., Tolley H., Denamur E. Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ Microbiol 2008, 10:2484-2496.
8. Clermont O., Christenson J.K., Denamur E., Gordon D.M. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep 2013, 5:58-65.
9. Platell J.L., Cobbold R.N., Johnson J.R., Heisig A., Heisig P., Clabots C., et al. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother 2011, 55:3782-3787.
10. Johnson J.R., Kuskowski M.A., Owens K., Clabots C., Singer R.S. Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection. Vet Microbiol 2009, 136:108-114.
11. Platell J.L., Cobbold R.N., Johnson J.R., Trott D.J. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J Antimicrob Chemother 2010, 65:1936-1938.
12. Sidjabat H.E., Townsend K.M., Lorentzen M., Gobius K.S., Fegan N., Chin J.J., et al. Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia. J Med Microbiol 2006, 55:1125-1134.
13. Clinical and Laboratory Standards Institute Performance standards for antimicrobial disk susceptibility tests: approved standard-eleventh edition M02-a11 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
14. Woodford N., Fagan E.J., Ellington M.J. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 2006, 57:154-155.
15. Clermont O., Johnson J.R., Menard M., Denamur E. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 2007, 57:129-136.
16. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009, 53:2733-2739.
17. Mora A., Blanco M., Lopez C., Mamani R., Blanco J.E., Alonso M.P., et al. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT: H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 2011, 37:16-21.
18. CTX-M-14 gene in clinical isolates of Escherichia coli from Korea. J Antimicrob Chemother 2011, 66:1263-1268.
19. Tamang M.D., Nam H.M., Jang G.C., Kim S.R., Chae M.H., Jung S.C., et al. Molecular characterization of extended-spectrum-beta-lactamase-producing and plasmid-mediated AmpC beta-lactamase-producing Escherichia coli isolated from stray dogs in South Korea. Antimicrob Agents Chemother 2012, 56:2705-2712.
20. Harada K., Nakai Y., Kataoka Y. Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 beta-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan. Microbiol Immunol 2012, 56:480-485.
21. Izdebski R., Baraniak A., Fiett J., Adler A., Kazma M., Salomon J., et al. Clonal structure, extended-spectrum beta-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob Agents Chemother 2013, 57:309-316.
22. Platell J.L., Cobbold R.N., Johnson J.R., Clabots C.R., Trott D.J. Fluoroquinolone-resistant extraintestinal Escherichia coli clinical isolates representing the O15:K52:H1 clonal group from humans and dogs in Australia. Comp Immunol Microbiol Infect Dis 2012, 35:319-324.
23. Staples M., Graham R.M., Doyle C.J., Smith H.V., Jennison A.V. Prolonged and mixed non-O157 Escherichia coli infection in an Australian household. Clin Microbiol Infect 2012, 18:E140-E143.
24. Lau S.H., Reddy S., Cheesbrough J., Bolton F.J., Willshaw G., Cheasty T., et al. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 2008, 46:1076-1080.
25. Blanco M., Alonso M.P., Nicolas-Chanoine M.H., Dahbi G., Mora A., Blanco J.E., et al. Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2009, 63:1135-1141.
26. Ewers C., Bethe A., Stamm I., Grobbel M., Kopp P.A., Guerra B., et al. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?. J Antimicrob Chemother 2014.
27. Suzuki S., Shibata N., Yamane K., Wachino J., Ito K., Arakawa Y. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009, 63:72-79.
28. CTX-M-14. J Med Microbiol 2011, 60:694-695.
29. Pitout J.D. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 2012, 3:9.